Atrium Health Cleveland/LCI-Cleveland is a clinical research site located in Shelby, North Carolina, United States 28150.
Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.
Atrium Health Cleveland/LCI-Cleveland has participated in 30 clinical trials with 20 currently active.
Therapeutic areas: Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease, Breast Ductal Carcinoma In Situ.
Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), NRG Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Shelby
Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Atrium Health Cleveland/LCI-Cleveland has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Atrium Health Cleveland/LCI-Cleveland has 30 clinical trials on record, with 20 currently active. Their work covers Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease, Breast Ductal Carcinoma In Situ.
Atrium Health Cleveland/LCI-Cleveland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.